Boston Foundation, Inc. - Net Worth and Insider Trading
Boston Foundation, Inc. Net Worth
The estimated net worth of Boston Foundation, Inc. is at least $533 dollars as of 2024-09-20. Boston Foundation, Inc. is the 10% Owner of Salarius Pharmaceuticals Inc and owns about 320 shares of Salarius Pharmaceuticals Inc (SLRX) stock worth over $533. Details can be seen in Boston Foundation, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Boston Foundation, Inc. has not made any transactions after 2019-01-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Boston Foundation, Inc.
Boston Foundation, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Boston Foundation, Inc. owns 1 companies in total, including Salarius Pharmaceuticals Inc (SLRX) .
Click here to see the complete history of Boston Foundation, Inc.’s form 4 insider trades.
Insider Ownership Summary of Boston Foundation, Inc.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SLRX | Salarius Pharmaceuticals Inc | 2019-01-09 | 10 percent owner |
Boston Foundation, Inc. Latest Holdings Summary
Boston Foundation, Inc. currently owns a total of 1 stock. Boston Foundation, Inc. owns 320 shares of Salarius Pharmaceuticals Inc (SLRX) as of January 9, 2019, with a value of $533.
Latest Holdings of Boston Foundation, Inc.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SLRX | Salarius Pharmaceuticals Inc | 2019-01-09 | 320 | 1.67 | 533 |
Holding Weightings of Boston Foundation, Inc.
Boston Foundation, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Boston Foundation, Inc. has made a total of 0 transactions in Salarius Pharmaceuticals Inc (SLRX) over the past 5 years. The most-recent trade in Salarius Pharmaceuticals Inc is the sale of 67 shares on January 9, 2019, which brought Boston Foundation, Inc. around $124,690.
Insider Trading History of Boston Foundation, Inc.
- 1
Boston Foundation, Inc. Trading Performance
Boston Foundation, Inc. Ownership Network
Boston Foundation, Inc. Owned Company Details
What does Salarius Pharmaceuticals Inc do?
Who are the key executives at Salarius Pharmaceuticals Inc?
Boston Foundation, Inc. is the 10 percent owner of Salarius Pharmaceuticals Inc. Other key executives at Salarius Pharmaceuticals Inc include Exec VP Finance & Interim CFO Mark J Rosenblum , director & Chief Executive Officer David J. Arthur , and Chief Financial Officer Scott Jordan .
Salarius Pharmaceuticals Inc (SLRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Salarius Pharmaceuticals Inc (SLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Salarius Pharmaceuticals Inc (SLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Salarius Pharmaceuticals Inc (SLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Salarius Pharmaceuticals Inc Insider Transactions
Boston Foundation, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Boston Foundation, Inc.. You might contact Boston Foundation, Inc. via mailing address: 75 Arlington Street, Boston Ma 02116.